Daptomycin: a review 4 years after first approval (Q36972980)

17 August 2017

1 reference

title

Daptomycin: a review 4 years after first approval (English)

1 reference

17 August 2017

Robert Sauermann

1

1 reference

17 August 2017

Markus Rothenburger

series ordinal

2

1 reference

17 August 2017

Wolfgang Graninger

series ordinal

3

1 reference

17 August 2017

Christian Joukhadar

series ordinal

4

1 reference

17 August 2017

16 October 2007

1 reference

17 August 2017

1 reference

17 August 2017

81

1 reference

17 August 2017

2

1 reference

17 August 2017

79-91

1 reference

Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model

17 August 2017

1 reference

Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia

21 January 2018

1 reference

Inhibition of membrane potential-dependent amino acid transport by daptomycin

21 January 2018

1 reference

In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin

21 January 2018

1 reference

Determination of the pharmacodynamic profile of daptomycin against Streptococcus pneumoniae isolates with varying susceptibility to penicillin in a murine thigh infection model

21 January 2018

1 reference

In vivo pharmacodynamic activity of daptomycin

21 January 2018

1 reference

Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection

21 January 2018

1 reference

Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects

21 January 2018

1 reference

Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers

21 January 2018

1 reference

Effect of protein binding of daptomycin on MIC and antibacterial activity

21 January 2018

1 reference

Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs

21 January 2018

1 reference

In vitro synergism between daptomycin and fosfomycin against Enterococcus faecalis isolates with high-level gentamicin resistance

21 January 2018

1 reference

The in vitro activity of daptomycin against Staphylococcus aureus and Enterococcus species

21 January 2018

1 reference

The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates

21 January 2018

1 reference

Population pharmacokinetics of daptomycin

21 January 2018

1 reference

The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections

21 January 2018

1 reference

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

21 January 2018

1 reference

Comparative tolerability of the HMG-CoA reductase inhibitors

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000109868

1 reference

17 August 2017

1 reference